Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
15°
Partly Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about RHHVF
Recent news which mentions RHHVF
< Previous
1
2
3
4
5
Next >
FDA Approves First Injectable Eye Medicine For Vision Loss Disorder - Genentech's Vabysmo
January 31, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
Market News
FDA
Benzinga
From
Benzinga
Genentech's Evrysdi Application Under FDA Priority Review For Use In Babies Below 2 Months
January 25, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
Health Care
RHHBY
General
From
Benzinga
CMS Proposes Coverage Of Biogen's Alzheimer's Drug, With Conditions Apply
January 12, 2022
Tickers
BIIB
ESALF
ESALY
LLY
Tags
Market News
Benzinga
FDA
From
Benzinga
Lineage, Genentech Ink Cell Therapy Licensing Pact For Ocular Diseases
December 20, 2021
Tickers
LCTX
RHHBF
RHHBY
RHHVF
Tags
Health Care
Contracts
Small Cap
From
Benzinga
Novartis Launches New Share Buyback Program Of Up To $15B
December 16, 2021
Tickers
NVS
RHHBF
RHHBY
RHHVF
Tags
RHHBF
RHHVF
General
From
Benzinga
After Roche Walks Away, Atea Puts Break On Late-Stage COVID-19 Oral Antiviral Trial
December 15, 2021
Tickers
AVIR
RHHBF
RHHBY
RHHVF
Tags
Phase 2 Trial
Market News
Benzinga
From
Benzinga
Roche's Polivy Combo Boosts Survival In Early-Stage Lymphoma Patients
December 14, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
Phase 3 Trial
General
RHHBY
From
Benzinga
Roche Uncorks Favorable Responses From Mosunetuzumab In Follicular Lymphoma Settings
December 13, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
General
RHHBY
ASH21
From
Benzinga
Infinity Pharma Shares Updated Eganelisib Combo Therapy In Breast Cancer Trial
December 10, 2021
Tickers
BMY
INFI
RHHBF
RHHBY
Tags
Benzinga
Penny Stocks
Phase 2 Trial
From
Benzinga
Roche Posts Encouraging Follow-up Data From Tiragolumab/Tecentriq Trial In Lung Cancer
December 10, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHBY
General
News
From
Benzinga
Europe Approves Roche's Tocilizumab For Patients With Severe COVID-19
December 07, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
Health Care
Biotech
FDA
From
Benzinga
Immunocore' ImmTAC Candidate Shows Early Response In Ovarian And Head & Neck Cancer Patients
December 06, 2021
Tickers
IMCR
RHHBF
RHHBY
RHHVF
Tags
RHHBY
Solid Tumor
General
From
Benzinga
Biden's New COVID-19 Plan Includes Reimbursement For Over The Counter, At-Home COVID Tests
December 03, 2021
Tickers
ABT
BDX
CI
CVS
Tags
Health Care
Market News
Benzinga
From
Benzinga
Gene Therapy-Focused Dyno Therapeutics Adds Astellas To List Partner List With $1.6B Pact
December 02, 2021
Tickers
ALPMF
ALPMY
NVS
RHHBF
Tags
RHHBF
RHHVF
Briefs
From
Benzinga
Roche's Gavreto Conditionally Approved In Europe For RET Fusion-Positive Lung Cancer
November 19, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
Biotech
Phase 1 Trial
European Medicines Agency
From
Benzinga
Novartis Has $21B From Roche Stake Sale - Which Company Is On Its M&A Radar?
November 18, 2021
Tickers
ALNY
BIIB
BMRN
DRNA
Tags
Movers
BMRN
News
From
Benzinga
Spark Therapeutics' Hemophilia Gene Therapy Shows Reduction In Bleeding Episodes
November 18, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
Briefs
News
RHHBY
From
Benzinga
Atea Shares Plunge As Roche Culls Partnership To Develop COVID-19 Pill
November 17, 2021
Tickers
AVIR
RHHBF
RHHBY
RHHVF
Tags
General
RHHBY
COVID/19 Coronavirus
From
Benzinga
Europe Approves Regeneron - Roche's COVID-19 Antibody Cocktail
November 12, 2021
Tickers
REGN
RHHBF
RHHBY
RHHVF
Tags
FDA
Benzinga
Market News
From
Benzinga
EU Regulator Backs Regeneron-Roche's COVID-19 Drug
November 11, 2021
Tickers
REGN
RHHBF
RHHBY
RHHVF
Tags
Market News
FDA
Benzinga
From
Benzinga
Hit By Slow Rollout, Biogen's Aduhelm Could Soon Find Itself In Price Competition: Reuters
November 10, 2021
Tickers
BIIB
LLY
RHHBF
RHHBY
Tags
LLY
FDA
Benzinga
From
Benzinga
ALX Oncology Falls After Updated Data For Solid Tumors Candidate
November 09, 2021
Tickers
ALXO
MRK
RHHBF
RHHBY
Tags
Movers
Briefs
News
From
Benzinga
Regeneron-Roche's COVID-19 Treatment Shows Long Term Benefit After Single Dose
November 08, 2021
Tickers
REGN
RHHBF
RHHBY
RHHVF
Tags
Phase 3 Trial
General
RHHBY
From
Benzinga
Novartis To Offload Its Stake Back To Roche For $20.7B
November 04, 2021
Tickers
NVS
RHHBF
RHHBY
RHHVF
Tags
Market News
Benzinga
Biotech
From
Benzinga
Galecto To Test GB1211 Combined with Roche's Tecentriq In First Line Lung Cancer Setting
November 02, 2021
Tickers
GLTO
RHHBF
RHHBY
RHHVF
Tags
Phase 2 Trial
Market News
Benzinga
From
Benzinga
Roche Expects Higher FY21 Sales As Delta Variant Boosts Demand For Diagnostics
October 20, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHVF
RHHBF
Guidance
From
Benzinga
AstraZeneca Pulls Plug On MCL-1 Cancer Drug Trial
October 20, 2021
Tickers
ABBV
AMGN
AZN
AZNCF
Tags
General
RHHBY
News
From
Benzinga
Why Are Atea Pharmaceuticals Shares Plunging Today?
October 19, 2021
Tickers
AVIR
RHHBF
RHHBY
RHHVF
Tags
Short Ideas
AVIR
RHHVF
From
Benzinga
Roche's Tecentriq Wins FDA Approval In Adjuvant Lung Cancer Setting
October 18, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
General
RHHBY
Briefs
From
Benzinga
Roche's Alzheimer's Candidate Secures FDA Breakthrough Designation
October 08, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
Alzheimer's disease
Biotech
FDA Breakthrough Designation
From
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.